Becker’s Healthcare Podcast podcast

Insights on GLP-1 Drugs and Medicare Advantage Trends with Jakob Emerson, Becker’s Healthcare

0:00
14:28
Rewind 15 seconds
Fast Forward 15 seconds

In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, joins Scott Becker to discuss the challenges surrounding GLP-1 drugs in the insurance space and the varied responses to Medicare Advantage headwinds. They explore Elevance Health’s strategies and share insights into how large and small insurers are navigating these issues.

More episodes from "Becker’s Healthcare Podcast"